INV-9956

Shenzhen Ionova Life Sciences Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	INV-9956
Sponsor	Shenzhen Ionova Life Sciences Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

INV-9956 CI brief — competitive landscape report
INV-9956 updates RSS · CI watch RSS
Shenzhen Ionova Life Sciences Co., Ltd. portfolio CI